G. Montgomery

No ORCID on file · 3 papers in corpus
preprint 2026
Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.
·doi:10.21203/rs.3.rs-8096027/v1

Abstract Progestins are important first line and adjuvant medications for endometriosis, yet their efficacy varies among patients. Dienogest (DNG), a 4th generation progestin, is one of the most prescribed and successful progestins, althou…

article 2022
7923 Establishment of the National Endometriosis Clinical and Scientific Trials (NECST) Registry in Australia
·doi:10.1016/j.jmig.2022.09.347
article 2022
A rare variant in the MARVELD2 gene is associated with Chinesen samples with ovarian endometriosis
·doi:10.31083/j.ejgo4301012

Objectives: Endometriosis is a common gynecological disease affecting up to ~10% of women at reproductive age. Prior combined studies implied that MARVELD2 might be involved in the pathogenesis of certain malignancies. Here, 211 Han Chinese…